Pediatric Biobanking involves the collection, processing, storage, and research use of biological samples from infants, children, and adolescents to advance scientific discovery and transform pediatric medicine. Biobanks play a critical role in genetics, rare disease research, oncology, infectious diseases, and precision medicine. This session explores ethical considerations, operational frameworks, sample integrity, data governance, and long-term stewardship of pediatric biospecimens. Clinicians and researchers often seek updated knowledge at a Pediatrics Conference to ensure their practices meet scientific, ethical, and regulatory standards.

Participants will examine how consent, assent, privacy, and community trust influence successful biobanking in pediatrics. The session highlights structured pediatric biobanking pathways that guide sample collection, processing, annotation, storage, and retrieval. Case examples demonstrate the use of biospecimens in genomic sequencing, biomarker discovery, pharmacology studies, developmental research, and disease surveillance.

Attendees will explore strategies for maintaining high-quality samples through validated protocols, cold-chain management, biorepository design, and robust laboratory practices. The discussion includes linking biospecimens with clinical data, imaging archives, environmental information, and longitudinal follow-up systems to support integrative research. Participants will learn how biobanking supports innovation in cancer immunology, gene therapy, vaccine development, early-detection tools, and computational biology.

Ethical considerations are emphasised throughout, including return-of-results policies, re-consenting procedures, incidental findings, data-sharing agreements, and community engagement. The session also addresses global disparities—many regions lack infrastructure, funding, trained personnel, or temperature-stable storage facilities—creating barriers to pediatric biobanking.

The session concludes with an exploration of automation, digital biobanks, AI-enabled sample matching, cloud-based data platforms, and sustainability practices that reduce environmental impact. By examining scientific, logistical, and ethical dimensions, this session prepares participants to strengthen biobank integrity and contribute to research that shapes the future of pediatric health.